Suchergebnisse - "Curtin, Nicola"

PubPharm (127)

61

PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia

enthalten in: Oncotarget | 2015

von Herriott, A. | Tudhope, S. | Junge, G. | +13

62

Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System

enthalten in: Molecular cancer therapeutics | 2015

von Parrish, K. | Cen, L. | Murray, J. | +11

63

Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition

enthalten in: Oncotarget | 2015

von Middleton, F. | Patterson, M. | Elstob, C. | +9

64

PARP activity in peripheral blood lymphocytes as a predictive biomarker for PARP inhibition in tumor tissues - A population pharmacokinetic/pharmacodynamic analysis of rucaparib

enthalten in: Clinical pharmacology in drug development | 2015

von Wang, D. | Li, C. | Sun, W. | +7

65

Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer

enthalten in: Molecular oncology | 2015

von Abdel-Fatah, T. | Middleton, F. | Arora, A. | +12

66

Development of pharmacodynamic biomarkers for ATR inhibitors

enthalten in: Molecular oncology | 2015

von Chen, T. | Middleton, F. | Falcon, S. | +3

67

DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2015

von Cornell, L. | Munck, J. | Alsinet, C. | +13

68

Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself

enthalten in: PloS one | 2015

von McCrudden, C. | O'Rourke, M. | Cherry, K. | +14

69

PARP Inhibitors for Cancer Therapy

Erschienen: [s.l.], Humana Press, 2015

Cancer Drug Discovery and Development - 83

von Curtin, N. | Sharma, R.

70

PARP Inhibitors for Cancer Therapy

Erschienen: Cham, Springer International Publishing AG, 2015

Cancer Drug Discovery and Development Ser.

von Curtin, N. | Sharma, R.